Effect of Cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival
Arlene Bardeguez(University Hospital, Newark), Mary Jo O’Sullivan(University at Buffalo, State University of New York), Lisa M. Frenkel(Infectious Disease Research Institute), Sharon Huang(FuelCell Energy (United States)), David E. Shapiro(Intercept Pharmaceuticals (United States)), Robert W. Coombs(University of Namur), Jorge Gandía(Hospital de Sant Pau), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Rhoda Sperling(MDS Associates (United States)), Mary Glenn Fowler(Johns Hopkins University), Carmen Zorrilla(University of Puerto Rico, Medical Sciences Campus), Robert Maupin, Theodore B. Jones(Wayne State University), Bethann E. Cunningham(Frontier Science & Technology Research Foundation, Inc.)
JAIDS Journal of Acquired Immune Deficiency Syndromes
February 1, 2003
Cited by 44
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k